BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 33020650)

  • 1. Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer.
    Wong M; Mayoh C; Lau LMS; Khuong-Quang DA; Pinese M; Kumar A; Barahona P; Wilkie EE; Sullivan P; Bowen-James R; Syed M; Martincorena I; Abascal F; Sherstyuk A; Bolanos NA; Baber J; Priestley P; Dolman MEM; Fleuren EDG; Gauthier ME; Mould EVA; Gayevskiy V; Gifford AJ; Grebert-Wade D; Strong PA; Manouvrier E; Warby M; Thomas DM; Kirk J; Tucker K; O'Brien T; Alvaro F; McCowage GB; Dalla-Pozza L; Gottardo NG; Tapp H; Wood P; Khaw SL; Hansford JR; Moore AS; Norris MD; Trahair TN; Lock RB; Tyrrell V; Haber M; Marshall GM; Ziegler DS; Ekert PG; Cowley MJ
    Nat Med; 2020 Nov; 26(11):1742-1753. PubMed ID: 33020650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research.
    Chang W; Brohl AS; Patidar R; Sindiri S; Shern JF; Wei JS; Song YK; Yohe ME; Gryder B; Zhang S; Calzone KA; Shivaprasad N; Wen X; Badgett TC; Miettinen M; Hartman KR; League-Pascual JC; Trahair TN; Widemann BC; Merchant MS; Kaplan RN; Lin JC; Khan J
    Clin Cancer Res; 2016 Aug; 22(15):3810-20. PubMed ID: 26994145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portals for Exploring Noncoding Variants in Pediatric Cancer.
    Creighton CJ
    Trends Genet; 2021 Apr; 37(4):297-298. PubMed ID: 33494957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
    Waszak SM; Northcott PA; Buchhalter I; Robinson GW; Sutter C; Groebner S; Grund KB; Brugières L; Jones DTW; Pajtler KW; Morrissy AS; Kool M; Sturm D; Chavez L; Ernst A; Brabetz S; Hain M; Zichner T; Segura-Wang M; Weischenfeldt J; Rausch T; Mardin BR; Zhou X; Baciu C; Lawerenz C; Chan JA; Varlet P; Guerrini-Rousseau L; Fults DW; Grajkowska W; Hauser P; Jabado N; Ra YS; Zitterbart K; Shringarpure SS; De La Vega FM; Bustamante CD; Ng HK; Perry A; MacDonald TJ; Hernáiz Driever P; Bendel AE; Bowers DC; McCowage G; Chintagumpala MM; Cohn R; Hassall T; Fleischhack G; Eggen T; Wesenberg F; Feychting M; Lannering B; Schüz J; Johansen C; Andersen TV; Röösli M; Kuehni CE; Grotzer M; Kjaerheim K; Monoranu CM; Archer TC; Duke E; Pomeroy SL; Shelagh R; Frank S; Sumerauer D; Scheurlen W; Ryzhova MV; Milde T; Kratz CP; Samuel D; Zhang J; Solomon DA; Marra M; Eils R; Bartram CR; von Hoff K; Rutkowski S; Ramaswamy V; Gilbertson RJ; Korshunov A; Taylor MD; Lichter P; Malkin D; Gajjar A; Korbel JO; Pfister SM
    Lancet Oncol; 2018 Jun; 19(6):785-798. PubMed ID: 29753700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of actionable genetic alterations with targeted panel sequencing in children with relapsed or refractory solid tumors.
    Lee JW; Kim NKD; Lee SH; Cho HW; Ma Y; Ju HY; Yoo KH; Sung KW; Koo HH; Park WY
    PLoS One; 2019; 14(11):e0224227. PubMed ID: 31747416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'.
    Langenberg KPS; Meister MT; Bakhuizen JJ; Boer JM; van Eijkelenburg NKA; Hulleman E; Ilan U; Looze EJ; Dierselhuis MP; van der Lugt J; Breunis W; Schild LG; Ober K; van Hooff SR; Scheijde-Vermeulen MA; Hiemcke-Jiwa LS; Flucke UE; Kranendonk MEG; Wesseling P; Sonneveld E; Punt S; Boltjes A; van Dijk F; Verwiel ETP; Volckmann R; Hehir-Kwa JY; Kester LA; Koudijs MMJ; Waanders E; Holstege FCP; Vormoor HJ; Hoving EW; van Noesel MM; Pieters R; Kool M; Stumpf M; Blattner-Johnson M; Balasubramanian GP; Van Tilburg CM; Jones BC; Jones DTW; Witt O; Pfister SM; Jongmans MCJ; Kuiper RP; de Krijger RR; Wijnen MHW; den Boer ML; Zwaan CM; Kemmeren P; Koster J; Tops BBJ; Goemans BF; Molenaar JJ
    Eur J Cancer; 2022 Nov; 175():311-325. PubMed ID: 36182817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome.
    Rusch M; Nakitandwe J; Shurtleff S; Newman S; Zhang Z; Edmonson MN; Parker M; Jiao Y; Ma X; Liu Y; Gu J; Walsh MF; Becksfort J; Thrasher A; Li Y; McMurry J; Hedlund E; Patel A; Easton J; Yergeau D; Vadodaria B; Tatevossian RG; Raimondi S; Hedges D; Chen X; Hagiwara K; McGee R; Robinson GW; Klco JM; Gruber TA; Ellison DW; Downing JR; Zhang J
    Nat Commun; 2018 Sep; 9(1):3962. PubMed ID: 30262806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Profiling of Hard-to-Treat Childhood and Adolescent Cancers.
    Khater F; Vairy S; Langlois S; Dumoucel S; Sontag T; St-Onge P; Bittencourt H; Dal Soglio D; Champagne J; Duval M; Leclerc JM; Laverdiere C; Tran TH; Patey N; Ellezam B; Perreault S; Piché N; Samson Y; Teira P; Jabado N; Michon B; Brossard J; Marzouki M; Cellot S; Sinnett D
    JAMA Netw Open; 2019 Apr; 2(4):e192906. PubMed ID: 31026031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth.
    Mody RJ; Wu YM; Lonigro RJ; Cao X; Roychowdhury S; Vats P; Frank KM; Prensner JR; Asangani I; Palanisamy N; Dillman JR; Rabah RM; Kunju LP; Everett J; Raymond VM; Ning Y; Su F; Wang R; Stoffel EM; Innis JW; Roberts JS; Robertson PL; Yanik G; Chamdin A; Connelly JA; Choi S; Harris AC; Kitko C; Rao RJ; Levine JE; Castle VP; Hutchinson RJ; Talpaz M; Robinson DR; Chinnaiyan AM
    JAMA; 2015 Sep; 314(9):913-25. PubMed ID: 26325560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing.
    Newman S; Nakitandwe J; Kesserwan CA; Azzato EM; Wheeler DA; Rusch M; Shurtleff S; Hedges DJ; Hamilton KV; Foy SG; Edmonson MN; Thrasher A; Bahrami A; Orr BA; Klco JM; Gu J; Harrison LW; Wang L; Clay MR; Ouma A; Silkov A; Liu Y; Zhang Z; Liu Y; Brady SW; Zhou X; Chang TC; Pande M; Davis E; Becksfort J; Patel A; Wilkinson MR; Rahbarinia D; Kubal M; Maciaszek JL; Pastor V; Knight J; Gout AM; Wang J; Gu Z; Mullighan CG; McGee RB; Quinn EA; Nuccio R; Mostafavi R; Gerhardt EL; Taylor LM; Valdez JM; Hines-Dowell SJ; Pappo AS; Robinson G; Johnson LM; Pui CH; Ellison DW; Downing JR; Zhang J; Nichols KE
    Cancer Discov; 2021 Dec; 11(12):3008-3027. PubMed ID: 34301788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations.
    Oberg JA; Glade Bender JL; Sulis ML; Pendrick D; Sireci AN; Hsiao SJ; Turk AT; Dela Cruz FS; Hibshoosh H; Remotti H; Zylber RJ; Pang J; Diolaiti D; Koval C; Andrews SJ; Garvin JH; Yamashiro DJ; Chung WK; Emerson SG; Nagy PL; Mansukhani MM; Kung AL
    Genome Med; 2016 Dec; 8(1):133. PubMed ID: 28007021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot precision medicine trial for children with diffuse intrinsic pontine glioma-PNOC003: A report from the Pacific Pediatric Neuro-Oncology Consortium.
    Mueller S; Jain P; Liang WS; Kilburn L; Kline C; Gupta N; Panditharatna E; Magge SN; Zhang B; Zhu Y; Crawford JR; Banerjee A; Nazemi K; Packer RJ; Petritsch CK; Truffaux N; Roos A; Nasser S; Phillips JJ; Solomon D; Molinaro A; Waanders AJ; Byron SA; Berens ME; Kuhn J; Nazarian J; Prados M; Resnick AC
    Int J Cancer; 2019 Oct; 145(7):1889-1901. PubMed ID: 30861105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Next-Generation Sequencing for Precision Oncology in Rare Cancers.
    Groisberg R; Hong DS; Roszik J; Janku F; Tsimberidou AM; Javle M; Meric-Bernstam F; Subbiah V
    Mol Cancer Ther; 2018 Jul; 17(7):1595-1601. PubMed ID: 29654067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid Tumor.
    Schienda J; Church AJ; Corson LB; Decker B; Clinton CM; Manning DK; Imamovic-Tuco A; Reidy D; Strand GR; Applebaum MA; Bagatell R; DuBois SG; Glade-Bender JL; Kang W; Kim A; Laetsch TW; Macy ME; Maese L; Pinto N; Sabnis AJ; Schiffman JD; Colace SI; Volchenboum SL; Weiser DA; Nowak JA; Lindeman NI; Janeway KA; Crompton BD; Kamihara J
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34964003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine.
    Van Allen EM; Robinson D; Morrissey C; Pritchard C; Imamovic A; Carter S; Rosenberg M; McKenna A; Wu YM; Cao X; Chinnaiyan A; Garraway L; Nelson PS
    Oncotarget; 2016 Aug; 7(33):52888-52899. PubMed ID: 27167109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline and Tumor Sequencing as a Diagnostic Tool To Resolve Suspected Lynch Syndrome.
    Pope BJ; Clendenning M; Rosty C; Mahmood K; Georgeson P; Joo JE; Walker R; Hutchinson RA; Jayasekara H; Joseland S; Como J; Preston S; Spurdle AB; Macrae FA; Win AK; Hopper JL; Jenkins MA; Winship IM; Buchanan DD
    J Mol Diagn; 2021 Mar; 23(3):358-371. PubMed ID: 33383211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited evolution of the actionable metastatic cancer genome under therapeutic pressure.
    van de Haar J; Hoes LR; Roepman P; Lolkema MP; Verheul HMW; Gelderblom H; de Langen AJ; Smit EF; Cuppen E; Wessels LFA; Voest EE
    Nat Med; 2021 Sep; 27(9):1553-1563. PubMed ID: 34373653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels.
    Ramarao-Milne P; Kondrashova O; Patch AM; Nones K; Koufariotis LT; Newell F; Addala V; Lakis V; Holmes O; Leonard C; Wood S; Xu Q; Mukhopadhyay P; Naeini MM; Steinfort D; Williamson JP; Bint M; Pahoff C; Nguyen PT; Twaddell S; Arnold D; Grainge C; Basirzadeh F; Fielding D; Dalley AJ; Chittoory H; Simpson PT; Aoude LG; Bonazzi VF; Patel K; Barbour AP; Fennell DA; Robinson BW; Creaney J; Hollway G; Pearson JV; Waddell N
    ESMO Open; 2022 Aug; 7(4):100540. PubMed ID: 35849877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing.
    Schuh A; Dreau H; Knight SJL; Ridout K; Mizani T; Vavoulis D; Colling R; Antoniou P; Kvikstad EM; Pentony MM; Hamblin A; Protheroe A; Parton M; Shah KA; Orosz Z; Athanasou N; Hassan B; Flanagan AM; Ahmed A; Winter S; Harris A; Tomlinson I; Popitsch N; Church D; Taylor JC
    Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29610388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care.
    Summers RJ; Castellino SM; Porter CC; MacDonald TJ; Basu GD; Szelinger S; Bhasin MK; Cash T; Carter AB; Castellino RC; Fangusaro JR; Mitchell SG; Pauly MG; Pencheva B; Wechsler DS; Graham DK; Goldsmith KC
    JCO Precis Oncol; 2022 Apr; 6():e2100451. PubMed ID: 35544730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.